Uncontrolled asthma is a risk factor for pregnancy-related complications. Hyaluronic acid (HA), a potential peripheral blood marker of tissue fibrosis in various diseases, promotes eosinophil survival and plays a role in asthmatic airway inflammation as well as in physiological processes necessary to maintain normal pregnancy; however the level of circulating HA in asthma and asthmatic pregnancy is unknown. We investigated HA levels in asthmatic patients (N = 52; asthmatic pregnant (AP) N = 16; asthmatic non-pregnant (ANP) N = 36) and tested their relationship to asthma control. Serum HA level was lower in AP than in ANP patients (27 [24.7–31.55] vs. 37.4 [30.1–66.55] ng/mL, p = 0.006); the difference attenuated to a trend after its adjustment for patients’ age (p = 0.056). HA levels and airway resistance were positively (r = 0.467, p = 0.004), HA levels and Asthma Control Test (ACT) total score inversely (r = ？0.437, p = 0.01) associated in ANP patients; these relationships remained significant even after their adjustments for age. The potential value of HA in the determination of asthma control was analyzed using ROC analysis which revealed that HA values discriminate patients with ACT total score ≥20 (controlled patients) and <20 (uncontrolled patients) with a 0.826 efficacy (AUC, 95% CI: 0.69–0.97, p = 0.001) when 37.4 ng/mL is used as cut-off value in ANP group, and with 0.78 efficacy (AUC, 95% CI: 0.65–0.92, p = 0.0009) in the whole asthmatic cohort. In conclusion circulating HA might be a marker of asthma control, as it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control. Decrease of HA level in pregnancy may be the consequence of pregnancy induced immune tolerance.
References
[1]
Global Initiative for Asthma. Available: http://www.ginasthma.org. Accessed 2013 Sep 17.
[2]
Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, et al. (2004) Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114(1): 40–7. doi: 10.1016/j.jaci.2004.04.042
[3]
Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, et al. (2000) The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161: 9–16. doi: 10.1164/ajrccm.161.1.9802048
[4]
Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, et al. (1996) Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51: 496–502. doi: 10.1136/thx.51.5.496
[5]
Volbeda F, Broekema M, Lodewijk ME, Hylkema MN, Reddel HK, et al. (2013) Clinical control of asthma associates with measures of airway inflammation. Thorax 68(1): 19–24. doi: 10.1136/thoraxjnl-2012-201861
[6]
Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, et al. (1995) Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med 151(5): 1354–1358. doi: 10.1164/ajrccm.151.5.7735584
[7]
Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, et al. (2006) High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation? Clin Exp Allergy 36(11): 1373–81. doi: 10.1111/j.1365-2222.2006.02502.x
[8]
Mukhopadhyay S, Hoidal JR, Mukherjee TK (2006) Role of TNFalpha in pulmonary pathophysiology. Respir Res 11 7: 125. doi: 10.1186/1465-9921-7-125
[9]
Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, et al. (2005) C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 60(6): 451–454. doi: 10.1136/thx.2004.035774
[10]
Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG (2012) The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 142(1): 86–93. doi: 10.1378/chest.11-1838
[11]
Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, et al. (2006) High sensitivity C-reactive protein in asthma. Eur Respir J 27(5): 908–912.
[12]
Ivancsó I, Toldi G, Bohács A, Eszes N, Müller V, et al. (2013) Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy. PLoS One. 8(4): e60697. doi: 10.1371/journal.pone.0060697
[13]
Kwon HL, Belanger K, Bracken MB (2003) Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 13: 317–324. doi: 10.1016/s1047-2797(03)00008-5
[14]
Demissie K, Breckenridge MB, Rhoads GG (1998) Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 158: 1091–1095. doi: 10.1164/ajrccm.158.4.9802053
[15]
Breton MC, Beauchesne MF, Lemière C, Rey E, Forget A, et al. (2009) Risk of perinatal mortality associated with asthma during pregnancy. Thorax 64: 101–106. doi: 10.1136/thx.2008.102970
[16]
Schatz M (1999) Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol 103: S330–336. doi: 10.1016/s0091-6749(99)70258-7
[17]
Murphy VE, Clifton VL, Gibson PG (2006) Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 61(2): 169–76. doi: 10.1136/thx.2005.049718
[18]
Tamasi L, Horvath I, Bohacs A, Muller V, Losonczy GY, et al. (2011) Asthma in pregnancy - Immunological changes and clinical management. Respir Med 105: 159–164. doi: 10.1016/j.rmed.2010.11.006
[19]
Murphy VE, Gibson PG (2011) Asthma in pregnancy. Clin Chest Med 32(1): 93–110, ix.
[20]
Schatz M, Dombrowski MP, Wise R, Lai Y, Landon M, et al. (2010) The relationship of asthma-specific quality of life during pregnancy to subsequent asthma and perinatal morbidity. J Asthma 47: 46–50. doi: 10.3109/02770900903483758
[21]
Almond A (2007) Hyaluronan. Cell Mol Life Sci 64: 1591–1596. doi: 10.1007/s00018-007-7032-z
[22]
Olczyk P, Komosinska-Vassev K, Winsz-Szczotka K, Kuznik-Trocha K, Olczyk K (2008) [Hyaluronan: structure, metabolism, functions, and role in wound healing]. Postepy Hig Med Dosw 62: 651–659. doi: 10.1515/cclm.2008.048
[23]
Grootveld MC, Henderson EB, Farrell A, Blake R, Parkes HG, et al. (1991) Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed joint: detection of abnormal low molecular weight metabolites by proton nuclear magnetic spectroscopy. Biochem J 273 (pt 2): 459–467.
Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev. 91(1): 221–264. doi: 10.1152/physrev.00052.2009
[29]
S？derberg M, Bjermer L, H？llgren R, Lundgren R (1989) Increased hyaluronan (hyaluronic acid) levels in bronchoalveolar lavage fluid after histamine inhalation. Int Arch Allergy Appl Immunol 88(4): 373–376. doi: 10.1159/000234719
[30]
Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, et al. (1998) Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 157(2): 403–409. doi: 10.1164/ajrccm.157.2.96-08040
[31]
Bousquet J, Chanez P, Lacoste JY, Enander I, Venge P, et al. (1991) Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 88: 649–660. doi: 10.1016/0091-6749(91)90159-l
[32]
Liang J, Jiang D, Jung Y, Xie T, Ingram J, et al. (2011) Role of hyaluronan and hyaluronan-binding proteins in human asthma. J Allergy Clin Immunol 128(2): 403–411.e3. doi: 10.1016/j.jaci.2011.04.006
[33]
Ohkawara Y, Tamura G, Iwasaki T, Tanaka A, Kikuchi T, et al. (2000) Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol 23: 444–451. doi: 10.1165/ajrcmb.23.4.3875
[34]
Cordo-Russo R, Garcia MG, Barrientos G, Orsal AS, Viola M, et al. (2009) Murine abortion is associated with enhanced hyaluronan expression and abnormal localization at the fetomaternal interface. Placenta. 30(1): 88–95. doi: 10.1016/j.placenta.2008.10.013
[35]
Kobayashi H, Sun GW, Tanaka Y, Kondo T, Terao T (1999) Serum hyaluronic acid levels during pregnancy and labor. Obstet Gynecol 93(4): 480–484. doi: 10.1016/s0029-7844(98)00526-2
[36]
Uzun H, Konukoglu D, Albayrak M, Benian A, Madazli R, et al. (2010) Increased maternal serum and cord blood fibronectin concentrations in preeclampsia are associated with higher placental hyaluronic acid and hydroxyproline content. Hypertens Pregnancy 29(2): 153–162. doi: 10.3109/10641950902968619
[37]
Berg S, Engman A, Holmgren S, Lundahl T, Laurent TC (2001) Increased serum hyaluronan in severe preeclampsia and eclampsia. Scand J Clin Lab Invest 61: 131–138. doi: 10.1080/00365510151097647
[38]
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319–338.
[39]
Lindqvist U, Laurent TC (1992) Serum hyaluronan and aminoterminal propeptide of type III procollagen. Variation with age. Scand J Clin Lab Invest 1992 52: 613–621. doi: 10.3109/00365519209115504
[40]
Tamási L, Bohács A, Pállinger E, Falus A, Rigó J Jr, et al. (2005) Increased interferon-gamma- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy 35: 1197–1203. doi: 10.1111/j.1365-2222.2005.02322.x
Engstrom-Laurent A, Laurent UBG, Lilia K, Laurent TC (1985) Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 45: 497–504. doi: 10.3109/00365518509155249
[43]
Jiang D, Liang J, Noble PW (2007) Hyaluronan in Tissue Injury and Repair. Ann Rev Cell Dev Biol 23: 435–461. doi: 10.1146/annurev.cellbio.23.090506.123337
[44]
Fuji Y, Shima M, Ando M, Adachi M, Tsunetoshi Y (2002) Effect of air pollution and environmental tobacco smoke on serum hyaluronate concentrations in school children. Occup Environ Med 59: 124–128. doi: 10.1136/oem.59.2.124
[45]
DaVeiga SP, Swaidani S, Comhair SA, Erzurum SC, Aronica MA (2009) Elevation of Hyaluronan Levels in Human Subjects with Atopic Asthma. 10.1164/ajrccm-conference. 179: A2852 (abstract)
[46]
Boulet L, Belanger M, Carrier G (1995) Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am. J. Respir Crit Care Med 152: 865–871. doi: 10.1164/ajrccm.152.3.7663797
